Research
Longevity Investors Map
A structured view of longevity capital, mapping investors, funds, family offices, and ecosystem capital providers by geography, thesis, focus areas, key people, and available profile evidence.
| Investor | Investor type | HQ | Investment focus | Profile / thesis | Known portfolio companies | Key people | Target groups | Links |
|---|---|---|---|---|---|---|---|---|
| 25M Health | Adjacent longevity investors | New York, United States | Biotech & aging scienceDigital health & AIClinics & care delivery | 25M Health is a healthtech venture studio and early-stage venture fund that incubates and invests in businesses offering innovative solutions to improve healthcare outcomes and make communities healthier. They focus on digital health, B2B healthcare IT, and B2B2C tech-enabled care delivery, primarily investing from Pre-seed to Series A in the United States. | Basalt HealthCanopyFlourishHandspring HealthLadderMidiSwap HealthTruehold | Kirk Posmantur, Chief Partnership Officer, Board Member, FounderFannie Chen, Chief Operating OfficerGrant Silow, General PartnerJamie Brown, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| 3i Fund / White Bay Group | Family Offices & UHNW Investors | New York, United States | Biotech & aging scienceClinics & care delivery | 3i Fund is a New York-based private investment fund providing flexible growth capital and structured finance solutions for innovative companies. | n/a | n/a | Professional & Institutional InvestorsFamily OfficesStartups / Founders (B2B) | |
| .406 Ventures | Adjacent longevity investors | Boston, United States | Core preventive health | .406 Ventures is an early-stage venture capital firm based in Boston, focusing on healthcare, data + AI, and cybersecurity. The firm is relevant to preventive health through its investments in disruptive healthcare solutions aimed at improving delivery and outcomes. | AbleToIora HealthBluebird Kids HealthFamilyWell | Trip Hofer, Venture PartnerGraham Brooks, PartnerGreg Dracon, PartnerJoanna Skoler Gilman, Chief Marketing and Communications Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| 5AM Ventures | Adjacent longevity investors | San Francisco, United States | Pharma/Drug discovery | 5AM Ventures is a leading investment firm focused on funding and building next-generation life sciences companies. They invest across biopharmaceuticals, drug delivery technologies, and life science instruments, aiming to solve important healthcare needs. | AchaogenCage TherapeuticsLifordi ImmunotherapeuticsFellowNvelop Therapeutics | Arthur Tzianabos, Venture PartnerBrian Daniels, Venture PartnerElliott Levy, Venture PartnerAndy J. Schwab, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| 7Wire Ventures | International longevity VCs | Chicago, United States | Core preventive health | 7wire Ventures is a Chicago-based venture capital firm that invests in early-stage to later-stage digital health companies. The firm's core thesis is to empower the "Informed Connected Health Consumer" by investing in technology-driven solutions that enhance healthcare delivery and consumer engagement, directly supporting preventive health and improved outco | LivongoNOCDFOLX HealthParsley HealthHomethriveWhen Insurance | Startups / Founders (B2B)Professional & Institutional Investors | ||
| Able Partners | Adjacent longevity investors | New York City, United States | Core preventive health | Able Partners is an early-stage consumer investment fund based in New York City, focused on health and wellness. The firm aims to support entrepreneurs building visionary brands that enhance consumers' daily lives by addressing the "Wellness Gap" in physical and mental health. | AlmaAlto NeuroscienceAmae HealthSeason HealthFunction HealthDUOSOura Ring | Alison Ryu, PartnerAmanda Eilian, Founding PartnerLisa Blau, Founding Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Accel | Adjacent longevity investors | Palo Alto, United States | Core preventive health | Accel is a global venture capital firm that partners with exceptional teams from inception through all phases of private company growth, primarily focusing on early- and growth-stage technology companies. The firm has demonstrated a clear interest in the preventive health and longevity sector, making strategic investments in companies aiming to extend human | Generation LabBioPeakAtlassianSlackSpotifyFlipkartFacebookDropbox | n/a | Startups / Founders (B2B)Professional & Institutional Investors | |
| AEVIS VICTORIA | Adjacent longevity investors | Fribourg, Switzerland | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | Aevis Victoria is a Swiss investment holding company that focuses on the high-value sectors of healthcare, hospitality, lifestyle, and infrastructure. Its core holdings include the Swiss Medical Network, one of the country's leading private clinic groups, and Nescens, a premier brand dedicated to better-aging and longevity medicine. | n/a | n/a | Clinics / Labs / Medical Professionals (B2B)Founded 2006 | |
| AF Ventures | Adjacent longevity investors | New York, United States | Wellness Platforms | AF Ventures is a venture capital fund investing in high-growth consumer product companies. The firm focuses on emerging growth stage businesses across food & beverage, health & wellness, personal & household care, beauty, and pet, with a clear relevance to preventive health through its focus on healthy living-oriented brands and wellness platforms. | ByHeartHello CakeJinxSiete Family FoodsGainfulCirkulHims & HersYumi | n/a | Startups / Founders (B2B)Professional & Institutional Investors | |
| age1 | International longevity VCs | San Francisco, United States | BiotechPharma/Drug discovery | age1 is a venture capital firm based in San Francisco, United States, focused on extending healthy human lifespan by investing in early-stage longevity biotech companies. The firm aims to revolutionize global healthcare systems by preventing age-related diseases rather than solely treating them. | ALX OncologyLoyalGordian BiotechnologySpring DiscoveryUnity BiotechnologyDecibel Therapeutics | Laura Deming, Co-Founder, Venture PartnerAlex Colville, Co-Founder, General PartnerCarol Magalhaes, NewCo Chief of StaffSatvik Dasariraju, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| Airtree VC | Adjacent longevity investors | Sydney, Australia | BiotechCore preventive healthWellness Platforms | Airtree VC is a network-powered venture capital firm based in Sydney, Australia, investing in early-stage technology companies across Australia and New Zealand. The firm demonstrates a clear interest in health tech, personalized healthcare, and founder well-being, aligning with preventive health and wellness platforms. | HumanMr YumCanva | Adrielle Touma, Investment ManagerCraig Blair, Co-founder and PartnerDaniel Petre AO, Co-founder and Partner EmeritusElicia McDonald, CEO & Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| AlbionVC | Adjacent longevity investors | London, United Kingdom | Core preventive health | AlbionVC is a UK-based venture capital firm established in 1996, managing approximately £1 billion in venture funds and investing in over 50 companies. The firm focuses on seed to Series B investments in B2B software, healthcare, and deeptech companies, with a significant emphasis on healthtech solutions that contribute to preventive health. | OvivaEllipticQuantexaAbcodia | Adam Chirkowski, PartnerAndrew Elder, Deputy Managing PartnerCat McDonald, PartnerChristoph Ruedig, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Alven | Adjacent longevity investors | Paris, France | Biotech | Alven is an independent early-stage venture capital firm based in Paris, France, with over 25 years of experience. The firm primarily invests in European technology startups at the Seed and Series A stages, focusing on a broad range of sectors including marketplaces, AI, fintech, and wellness brands, which aligns with preventive health through its health tec | StripeQontoTypologyGorgiasYuboKestraGenerareVerley | Charles Letourneur, Managing PartnerFrançois Meteyer, PartnerGuillaume Aubin, Managing PartnerMaria Tahri, Principal | Startups / Founders (B2B)Professional & Institutional Investors | |
| Amaranth Foundation | Family Offices & UHNW Investors | San Francisco, United States | Biotech & aging scienceDigital health & AI | Amaranth Foundation funds ambitious research at the intersection of longevity, neuroscience and frontier science, with public grantmaking around aging biology, brain aging, neuroAI, centenarian genetics and biopreservation. | n/a | James Fickel, FounderJoanne Peng, Project DirectorRaiany Romanni, Policy & EthicsRohan Krajeski, Neuroscience | Professional & Institutional InvestorsFamily OfficesStartups / Founders (B2B) | |
| Amboy Street Ventures | International longevity VCs | Los Angeles, United States | Core preventive health | Amboy Street Ventures is a venture capital fund based in Los Angeles, United States, that focuses on Seed and Series A investments in Women's Health and Sexual Wellbeing for all genders. The firm aims to address the untapped $1 trillion market opportunity in these areas, making it highly relevant to preventive health by supporting innovations in fertility, c | EvvyContralineAlloyBea FertilityHeyJaneTestmateGranata BioAunt Flow | Dominnique Karetsos, Venture PartnerMafe Pereza Godoy, Venture PartnerCarli Sapir, Founding PartnerColleen Foster, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Amino Collective | International longevity VCs | Berlin, Germany | BiotechCore preventive health | Amino Collective is an early-stage venture capital firm based in Berlin, Germany, specializing in health and biotechnology investments. The firm focuses on European ventures with global ambitions, backing entrepreneurs and scientists in pre-seed and seed rounds. Its investment thesis aligns with preventive health through its focus on digital health, personal | AllcyteAnimaAwareAwellBiomia | n/a | Startups / Founders (B2B)Professional & Institutional Investors | |
| aMoon | Adjacent longevity investors | Ra'anana, Israel | Biotech & aging scienceDigital health & AIClinics & care delivery | aMoon is a global HealthTech and Life Sciences investment fund based in Israel, partnering with entrepreneurs to transform healthcare through groundbreaking science and technology. The fund invests in early and late-stage companies, focusing on biopharma, digital health, and medical technology to accelerate cure and promote a proactive, personalized approach | OmadaIbexAtaCor MedicalMDClone | Isaac Devash, Venture PartnerSamuel Moed, Venture PartnerNoah Lasson, JD, Chief Compliance Officer & CISOOsnat Tirosh, Chief People Officer & Chief of Staff | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ananda VC | Adjacent longevity investors | Munich, Germany | BiotechCore preventive health | Ananda Impact Ventures is a leading European impact venture capital firm based in Munich, Germany, focused on early-stage technology-driven startups. The firm invests across various scales, from planetary to molecular, with a strong emphasis on solutions that improve people's health and quality of life, making it relevant to preventive health and longevity. | iesoClose Loop MedicineOroraTechNatureMetricsDifferential BioResistomap | Alina Bassi, PrincipalBernd Klosterkemper, PartnerFlorian Erber, General Partner & FounderJohannes Weber, General Partner & Founder | Startups / Founders (B2B)Professional & Institutional Investors | |
| Andera Partners Life Sciences | International longevity VCs | Paris, France | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care delivery | Andera Partners Life Sciences is a venture capital fund based in Paris, France, specializing in investments in companies developing breakthrough therapeutic products and medical technologies. The fund targets innovative medical solutions from preclinical stages to commercialization across Europe and the US. | Alveus TherapeuticsInventivaSpiro MedicalAbivax | Loan Hoang-Sayag, Venture PartnerThierry Hercend, Venture PartnerAneta Sottil, PartnerElyes Chouaieb, Investment Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| Andreessen Horowitz (a16z) | Adjacent longevity investors | Menlo Park, United States | BiotechPharma/Drug discovery | Andreessen Horowitz (a16z) is a prominent venture capital firm with a dedicated Bio + Health fund, investing in founders who are redefining medicine and healthcare. They focus on multidisciplinary leaders driving medical breakthroughs, tackling diseases, and building modern healthcare infrastructure, with a strong emphasis on leveraging AI and engineering bi | BenchlingMindstrongRoSana BiotechnologyNautilus BiotechnologyPatientPingClair HealthInsitro | Ben Horowitz, Co-Founder & General PartnerMarc Andreessen, Co-Founder & General Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Apeiron Investment Group | Family Offices & UHNW Investors | Germany / United Kingdom | Biotech & aging scienceDigital health & AIClinics & care delivery | Apeiron Investment Group is Christian Angermayer’s discretionary investment firm, backing life sciences, biotechnology, future technologies and other “next human agenda” themes with long-term entrepreneurial capital. | atai Life SciencesCambrian BiopharmaRejuveron Life SciencesCompass Pathways | Aaron Weaver, Senior PartnerChristian Angermayer, Founder and Owner | Professional & Institutional InvestorsFamily OfficesStartups / Founders (B2B) | |
| Apex Ventures | Adjacent longevity investors | Vienna, Austria | BiotechPharma/Drug discovery | Apex Ventures is a European deep-tech and medical-focused venture capital firm based in Vienna, Austria. The firm invests in early-stage companies, primarily at the pre-seed, seed, and Series A stages, with a mission to build the next generation of world's leading companies. Their focus on medical and deep-tech solutions, including biotechnology and medical | contextflow | Andreas Riegler, Founder & General PartnerGolnaz Borghei, PrincipalIon Hauer, PrincipalMarcell Farkas, Chief Financial Officer | Startups / Founders (B2B)Professional & Institutional Investors | |
| Apollo Health Ventures | International longevity VCs | Berlin, Germany | BiotechPharma/Drug discovery | Apollo Health Ventures is a transatlantic early-stage Venture Capital firm that actively co-founds and invests in transformative healthcare companies. Their investment focus is on age-related diseases and aging itself, aiming to enhance healthy lifespans through scientific breakthroughs in biotechnology and health tech. | Auron TherapeuticsTherini BioHAYA TherapeuticsAeovian PharmaceuticalsThymofoxOchre BioRefoxy Pharmaceuticals | Alexandra Bause, Co-Founder & Venture PartnerChris Shepard, Venture PartnerGerd Hummel, Venture PartnerAntoine Boulanger, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Archangel Ventures | Adjacent longevity investors | Melbourne, Australia | Core preventive health | Archangel Ventures is an Australian venture capital firm that provides pre-seed and seed funding, as well as early-stage venture capital, to technology startups across Australia and Southeast Asia. The firm has a notable focus on health tech, aiming to support companies that drive innovation and improve healthcare efficiency. | Heidi HealthAtelierPearlerRelevance AIEarth Blox | Andrew Cicutto, PartnerBen Armstrong, Managing PartnerRayn Ong, PartnerGrace Liang, Head of Investor Relations and Operations | Startups / Founders (B2B)Professional & Institutional Investors | |
| Arkitekt Ventures | International longevity VCs | New York, United States | BiotechCore preventive health | Arkitekt Ventures is an early-stage venture fund based in New York, United States, specializing in novel models of healthcare delivery and frontier technology applications to medicine. The firm invests in visionary entrepreneurs transforming cutting-edge science and technology into solutions that radically improve and advance human health, with a strong rele | CofertilityOlli HealthStandard Model BiomedicineMural HealthTiaNaniteParsley HealthNOVOS | n/a | Startups / Founders (B2B)Professional & Institutional Investors | |
| ARTIS Ventures | Adjacent longevity investors | San Francisco, United States | Biotech & aging scienceDiagnostics & biomarkersDigital health & AIClinics & care deliveryConsumer health & wellness | ARTIS Ventures is a venture capital firm that partners with founders advancing global resilience through critical technologies that heal, protect, and sustain society. They focus on TechBio and Frontier Tech, leveraging AI and engineered technologies across various stages of venture investment. | PalantirEkoCohesityConceivable Life Sciences | Austin Walne, Senior PartnerHenry Klingenstein, PartnerJeff Sheedy, PartnerKash Chandarana, Co-Founder Luxe Brand Assets; Alma Hotel Management | Startups / Founders (B2B)Professional & Institutional Investors | |
| Asabys Partners | International longevity VCs | Barcelona, Spain | Biotech | Asabys Partners is a Barcelona-based investment firm focused on fostering breakthrough innovation in healthcare and life sciences. They invest in disruptive and transformative technologies with the aim of improving patients' lives, including solutions relevant to diagnostics and therapeutic care. | Binx HealthXR HealthAccure TherapeuticsAgomabInbrain NeuroelectronicsGradient Denervation Technologies | Clara Campàs, Co-founder and managing partnerEmilio Erazo-Fischer, Operating PartnerGuillem Masferrer, PartnerJose María Fernández, Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ascension VC | International longevity VCs | London, United Kingdom | BiotechConsumer TechCore preventive health | Ascension VC is a London-based early-stage venture capital firm that invests in pre-seed and seed technology startups across the UK, with a focus on mission-driven and impact-oriented founders. The firm has a dedicated interest in HealthTech, making it relevant to preventive health and longevity research. | Credit Kudos | Chris Wheatcroft, Investment PartnerEmma Steele, PartnerIulia Tudor, Ascension Fund III PartnerJean de Fougerolles, Managing Partner | Startups / Founders (B2B)Professional & Institutional Investors | |
| Ascension Ventures | Adjacent longevity investors | St. Louis, United States | Core preventive health | Ascension Ventures is a strategic healthcare venture fund and innovation catalyst with over $1 billion in capital under management. It focuses on investing in smarter technologies, bigger data, better alternatives, and healthier futures within the healthcare ecosystem. | Strive HealthClarify HealthLivongoMedically Home | Jamie Wehrung, Chief Administrative OfficerEmily Kuhns, Finance DirectorJohn Kuelper, Senior Managing DirectorPooja Goel, Managing Director | Startups / Founders (B2B)Professional & Institutional Investors | |
| ASICS Ventures | Adjacent longevity investors | Kobe, Japan | Core preventive health | ASICS Ventures is the corporate venture capital arm of ASICS, established to accelerate innovation in sports through investments and collaborations with cutting-edge technology startups globally. Its investment focus aligns with ASICS' "VISION2030" to promote healthy and fulfilled lives, making it relevant to preventive health and longevity. | PICKLEBALL ONECurv HealthOME Health | n/a | Startups / Founders (B2B)Professional & Institutional Investors |
| Category | Definition | Examples | Investors |
|---|---|---|---|
| Funds (Tech, Bio, Crypto) that do not exclusively target longevity but have a significant track record of investing in the sector. | 25M Health, .406 Ventures, 5AM Ventures, Able Partners, Accel | 18 | |
| Private wealth management entities actively deploying capital into the longevity ecosystem (direct deals or via funds). | 3i Fund / White Bay Group, Amaranth Foundation, Apeiron Investment Group | 3 | |
| Foreign venture capital funds that are highly active in the Swiss ecosystem, co-investing with Swiss funds or funding Swiss startups. | 7Wire Ventures, age1, Amboy Street Ventures, Amino Collective, Andera Partners Life Sciences | 9 |
| Focus area | What it captures | Representative investors | Investors |
|---|---|---|---|
| Biotech & aging science | Investors backing therapeutics, aging biology, regenerative medicine, drug discovery, and platform biotech. | 8 | |
| Diagnostics & biomarkers | Capital providers connected to diagnostics, omics, biomarker testing, clinical labs, and longitudinal measurement. | 3 | |
| Digital health & AI | Investors exposed to software, digital care, AI, remote monitoring, health platforms, and data infrastructure. | 7 | |
| Clinics & care delivery | Investors around preventive health, clinic groups, medical longevity centers, and care-delivery platforms. | 7 | |
| Consumer health & wellness | Capital providers backing consumer longevity, wellness, performance, supplements, and health optimization brands. | 2 |
This investor map is a research draft for informational purposes only. Investor strategy, portfolio exposure, fund status, and links may change over time and should be independently verified before editorial, investment, fundraising, or partnership decisions.